Filing Details

Accession Number:
0001179110-10-008560
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-05-13 13:00:00
Reporting Period:
2010-05-12
Filing Date:
2010-05-13
Accepted Time:
2010-05-13 17:03:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1323974 Mwi Veterinary Supply Inc. MWIV Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047) 020620757
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1334074 P Bryan Mooney 651 S. Stratford Drive, Suite 100
Meridian ID 83642
Vice President Of Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.01 Per Share Acquisiton 2010-05-12 10,000 $17.00 19,560 No 4 M Direct
Common Stock, Par Value $0.01 Per Share Acquisiton 2010-05-12 2,000 $22.60 21,560 No 4 M Direct
Common Stock, Par Value $0.01 Per Share Disposition 2010-05-12 17,800 $48.83 3,760 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, Par Value $0.01 Per Share Employee Stock Option (right to buy) Disposition 2010-05-12 10,000 $0.00 10,000 $17.00
Common Stock, Par Value $0.01 Per Share Employee Stock Option (right to buy) Disposition 2010-05-12 2,000 $0.00 2,000 $22.60
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2005-09-15 2015-08-03 No 4 M Direct
0 2005-09-26 2015-09-26 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $48.3937 to $49.0200, inclusive. Mr. Mooney has provided to MWI Veterinary Supply, Inc. (the "Company") and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.